• News by Topic

  • News by Topic

  • Relationships news

  • Mind and body

    "Live as if your were to die tomorrow. Learn as if you were to live forever. You must learn to be still in the midst of activity and be vibrantly alive in repose."


This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.


FDA Approves New Alzheimer's Medication

The Food and Drug Administration approved the New Drug Application for Namzaric to treat moderate to severe Alzheimer’s. Namzaric is a fixed-dose combination of extended-release memantine hydrochloride, a NMDA receptor antagonist, and donepezil hydrochloride, an acetylcholinesterase inhibitor.These two medications are often co-prescribed for Alzheimer’s patients, and a recent clinical study demonstrated that giving memantine to patients already taking acetylcholinesterase inhibitors could boost improvements in cognition and functioning, with minimal adverse effects.This new dual-formula drug will reduce the number of pills Alzheimer’s patients need to take daily; the capsule can also...


Share |

Published By: Psychiatric News - Monday, 29 December, 2014

Copyright © 2016 Psychology One. All rights reserved. This site is for education & information purposes. This site is not a substitute for professional psychological, medical or psychiatric treatment.